Stay updated on ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedA sitewide NIH announcement banner links to transition updates and says that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check12 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check33 days agoChange DetectedRemoval of the 403 Forbidden HTML block and Home link indicates the previous access error is resolved and the page is positioned to display its standard content.SummaryDifference0.5%

- Check39 days agoChange DetectedA 403 Forbidden error page is now displayed when attempting to view the study record, replacing the expected content with an access-restricted message. This indicates the page is blocked and the study details are not accessible at this time.SummaryDifference20%

- Check60 days agoChange DetectedA 2014 U.S. NIH Grant/Contract note was added and the page revision updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

Stay in the know with updates to ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.